Abstract: A tubular electrospun graft implant is provided distinguishing an electrospun tubular layer which has a longitudinal axis and an outer surface. Polymer layers of an electrospun sheet have been rolled over the outer surface of the electrospun tubular layer and around the longitudinal axis of the electrospun tubular layer. A polymer layer electrospun is further distinguished over the rolled polymer layers of the electrospun sheet. Also provided is a tubular graft implant having layers of an electrospun polymer sheet rolled around a longitudinal axis defining the inner diameter of the tubular graft implant. These layers of the electrospun polymer sheet are moving independent from each other when the tubular graft implant is bending. Compared to regular spun graft, higher burst pressure is achieved, and crushing zones have been created between the layers to reduce the bending stiffness and facilitate bending with superior kink resistance.

Abstract: A cardiovascular graft is provided with highly reduced thrombogenicity. The cardiovascular graft is an electrospun non-woven mesh produced from supramolecular polymers with large diameter fibers. The cardiovascular graft can be implemented as a vascular graft into the human body to allow vascular bypass/reconstruction, or repeated venous access for dialysis treatment, as well as other disorders of small-diameter blood vessels.

Abstract: A cardiovascular graft is provided with highly reduced thrombogenicity. The cardiovascular graft is an electrospun non-woven mesh produced from supramolecular polymers with large diameter fibers. The cardiovascular graft can be implemented as a vascular graft into the human body to allow vascular bypass/reconstruction, or repeated venous access for dialysis treatment, as well as other disorders of small-diameter blood vessels.

Abstract: Bioabsorbable medical devices such as vascular closures, mitral chorea replacements, and mitral leaflet extensions are provided.

Abstract: A heart valve with reinforced leaflets is provided. The free edge of the leaflet and/or the leaflet belly area of the leaflet has a circumferentially aligned band of aligned electrospun fibers with non-aligned fibers. The aligned and/or the non-aligned fibers are bioabsorbable polymer fibers, and are capable of being replaced over time with newly formed tissue. A method is provided to make these heart valve leaflets using two sources of electrospinning which electrospun simultaneously to either form distinct layers or intermixed layers of aligned and non-aligned fibers.

Abstract: Bioabsorbable medical devices such as vascular closures, mitral chorea replacements, and mitral leaflet extensions are provided.

Abstract: A method of making a medical implant is provided by electrospinning a polymer solution to form a preform around a mandrel. The formed preform distinguishes an inner surface and an outer surface. The formed preform is removed from the mandrel and flipped inside-out resulting in the inner surface of the formed preform becoming the outer surface of the inside-out flipped preform, and the outer surface of the formed preform becoming the inner surface of the inside-out flipped preform. At least part of the inside-out flipped preform forms the medical implant such as e.g. an artificial heart valve, an artificial leaflet, an artificial graft, or an artificial vessel. The products made according to the method of this invention greatly improve the performance and durability of the medical implant.

Abstract: Multi-layered engineered designs are provided for heart valve leaflets. The multiple layer designs have significantly improved mobility of the leaflets, without reduced durability, compared to an ordinary single-layer design. In addition, a folded double layer design also showed highly reduced the risk of fraying.

Abstract: Bioabsorbable medical devices such as vascular closures, mitral chorea replacements, and mitral leaflet extensions are provided.

Abstract: Methods and the resulting structures, like valve devices (e.g. heart or vessel) are provided made by electrospinning single shapes on mandrels with complex surface shapes. These single shapes are then shaped into valves with a plurality of leaflets. Three levels of complexity of shapes are described: 1) conical shapes, 2) a combination of conical and cylindrical shapes, and 3) a conical and/or cylindrical shape which has further complexity by one or more three-dimensional shapes. Heart valves resulting from these complex electrospun shaped mandrels have better mobility dynamics compared to heart valves electrospun on solely cylindrical mandrels.

Abstract: The disclosure lies in the field of regenerative medicine and relates to an implant having a matrix material, and a method for manufacturing an implant having matrix material. The disclosure further relates to a crimped implant.

Abstract: Bioabsorbable medical devices such as vascular closures, mitral chorea replacements, and mitral leaflet extensions are provided.

Abstract: A medical implant for enhanced durability and wear reduction is provided that distinguishes a medical implant support structure, an electrospun cover layer covering at least a portion of the medical implant support structure, and an electrospun medical implant layer covering the electrospun cover layer such that the electrospun cover layer is an in-between layer in between the portion of the medical implant support structure and the electrospun medical implant layer. Such implant prevents direct contact for the medical implant support structure with the electrospun medical implant layer and thereby ensures that the electrospun cover layer is in direct contact with the electrospun medical implant layer.

Abstract: A medical implant is provided that has a first and a second electrospun component with the same type of biodegradable electrospun polymers. In one example, the second electrospun component is separately manufactured from the first electrospun component. Furthermore, the implant is structured such that the first electrospun component and the second electrospun component are assembled or joint together by the same type biodegradable electrospun polymers as in the first electrospun component and the second electrospun component. The assembled implant is a porous, biodegradable medical implant capable of being replaced by naturally ingrown tissue over time upon implantation. Advantages are the avoidance of sutures and the problems associated with the use of sutures, capability of ETR, avoidance of the need for extra materials, allowance for more precise and reproducible assembled structures for which the process could be automated.

Abstract: A cardiovascular graft is provided with highly reduced thrombogenicity. The cardiovascular graft is an electrospun non-woven mesh produced from supramolecular polymers with large diameter fibers. The cardiovascular graft can be implemented as a vascular graft into the human body to allow vascular bypass/reconstruction, or repeated venous access for dialysis treatment, as well as other disorders of small-diameter blood vessels.

Abstract: A method of making a medical implant is provided by electrospinning a polymer solution to form a preform around a mandrel. The formed preform distinguishes an inner surface and an outer surface. The formed preform is removed from the mandrel and flipped inside-out resulting in the inner surface of the formed preform becoming the outer surface of the inside-out flipped preform, and the outer surface of the formed preform becoming the inner surface of the inside-out flipped preform. At least part of the inside-out flipped preform forms the medical implant such as e.g. an artificial heart valve, an artificial leaflet, an artificial graft, or an artificial vessel. The products made according to the method of this invention greatly improve the performance and durability of the medical implant.

Abstract: A biodegradable cardiovascular implant is provided for growing cardiovascular tissue in a patient. The implant distinguishes an electro-spun network with supramolecular compounds having hard-blocks covalently bonded with soft-blocks resulting in much enhanced durability and fatigue resistance, while maintaining the effectiveness as a cardiovascular implant.

Abstract: The present disclosure relates to in situ tissue engineering, more specifically in situ vascular tissue engineering with the aim of providing a tissue structure which can be used e.g. as a substitute blood vessel or as a blood vessel functioning as cannulation site in hemodialysis. In particular, the disclosure involves tissue structure formation around a subcutaneously implanted synthetic rod. In addition, the disclosure involves a method for producing said synthetic rod.

Abstract: Endoluminal and other as implantable prostheses are fabricated in electrospinning apparatus including a target and an applicator. A solution comprising a polymer and a solvent is directed to the target with a first electrical potential between the target and the applicator to produce a first set of fibers. The same or another solution is continued to be delivered through the applicator onto the target while applying a second electrical potential to produce a second set of fibers having a second solvent fraction, and the same or different solution may be delivered while applying a third potential difference to produce a laminated structure having at least three layers. By properly controlling the electrical potentials and solvent fractions, an adhesive layer can be formed to serve a glue or adhesive between the inner and outer layers, and a stent or other scaffold may be positioned between the inner and outer layers to form a covered stent or graft.

Abstract: The disclosure lies in the field of regenerative medicine and relates to an implant having a matrix material, and a method for manufacturing an implant having matrix material. The disclosure further relates to a crimped implant.